tiprankstipranks
Revolution Medicines price target raised to $87 from $82 at Guggenheim
PremiumThe FlyRevolution Medicines price target raised to $87 from $82 at Guggenheim
3M ago
Revolution Medicines price target raised to $71 from $63 at JPMorgan
Premium
The Fly
Revolution Medicines price target raised to $71 from $63 at JPMorgan
3M ago
Revolution Medicines announces $600M common stock offering
Premium
The Fly
Revolution Medicines announces $600M common stock offering
3M ago
Revolution Medicines price target raised to $70 from $57 at Piper Sandler
PremiumThe FlyRevolution Medicines price target raised to $70 from $57 at Piper Sandler
4M ago
Revolution Medicines price target raised to $72 from $60 at Barclays
Premium
The Fly
Revolution Medicines price target raised to $72 from $60 at Barclays
4M ago
Revolution Medicines price target raised to $64 from $62 at H.C. Wainwright
Premium
The Fly
Revolution Medicines price target raised to $64 from $62 at H.C. Wainwright
4M ago
Revolution Medicines price target raised to $60 from $55 at Oppenheimer
PremiumThe FlyRevolution Medicines price target raised to $60 from $55 at Oppenheimer
4M ago
Revolution Medicines presents initial data from RMC-9805 study
Premium
The Fly
Revolution Medicines presents initial data from RMC-9805 study
4M ago
Revolution Medicines data validates RMC-6236’s anti-tumor activity, says Wedbush
Premium
The Fly
Revolution Medicines data validates RMC-6236’s anti-tumor activity, says Wedbush
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100